Docstoc

2003

Document Sample
2003 Powered By Docstoc
					대한생물정신의학회

1. 총회 및 이사회
  2004년 정기총회를 7월 15일(목)에 가톨릭 의과학 연구원에서 개최하여 2003년도결산보고와 회계
    감사가 있었다. 또한 2004년-2006년 회기의 이사장으로 이민수 회원, 회장으로 백인호 회원, 감
    사로 함웅, 손봉기 회원이 선출되었다. 현재 대한생물정신의학회는 64명의 평생회원과 80명의 정
    회원이 활동을 하고 있고, 현재까지 매달 첫째주 목요일에 상임이사회 회의가 개최되어 학회활동
    에 대한 다양한 토론이 있었다.


2. 학술지 발간
   생물정신의학회 10권2호(2003년 12월호)와 11권 1호(2004년 6월호)가 발간되었다.


3. 2003년도 추계학술대회 및 연수교육
  일시: 2003년 11월7일 (금)          오전 9시30분-오후 5시
  장소: 가톨릭대학교 의과학연구원 2층 대강당


  제 1부. 연수교육
  The Molecular foundations of psychiatry
  Introduction to Molecular Biology                       이민수 (고려의대)
  Overview of Synaptic Neurotransmission                  김영훈 (인제의대)
  Neural Plasticity: How Psychotropic Drugs Work          김용구 (고려의대)
  Overview of Psychiatric Genetics                        김도관 (성균관의대)
  Poster session


  제 2부. 특별강연
  Influence of Early Environment on Hippocampal Functions
  (Prof. Kanba, Department of Neuropsychiatry, Yamanashi University and Kyushu University,
  Japan)
  Early improvement with mirtazapine predicts later stable response and
  remission with high sensitivity in patients with major depression."
  (Armin Szegedi, M.D.,   Department of Psychiatry, University of Mainz, Germany)


  제 3부.    심포지움
  A New Paradigm for Antipsychotic Drugs
  Pharmacokinetic & Pharmacodynamic consideration
  of new antipsychotics                                         김찬형(연세의대)
  Pharmacogenomics of antipsychotic drugs             전태연(가톨릭의대)
  Typical antipsychotics in atypical era              이중서(한림의대)


  우수포스터 시상
4. WFSBP Precongress in Caines
   일시 : 2004년 2월 6-7일
   장소: 호주, 케인즈



   Symposium I. Psychopharmacology algorithm of Mood Disorder in Asian Countries
   1. Korean Medication Algorithm for Major Depressive Disorder (Min-Soo Lee, Korea)
   2. Korean Medication Algorithm for Bipolar Disorder. (Young Chul Shin, Korea)
   3. The Guidelines for the treatments of mood disorders in Japan.(Teruhiko Higuchi, Japan)
   4. Medication algorithm for mood disorders: Present status and future direction in Japan
      (Soichiro Nomura, Japan)


   Symposium 2. Clinical Applications of Psychiatric Genetics
   1. Genetic factors of late-onset Alzheimer’s disease; Their interpretation (Kouzin Kamiro,
      Japan)
   2. Serotonin Transporter Promoter Gene Polymorphism and Long-term Outcome of
      Antidepressant Treatment (Min Soo Lee, Korea)
   3. Predictability of antidepressant therapeutic effect by gene expression (Doh Kwan Kim,
      Korea)
   4. Eye movements and gene for schizophrenia (Takuya Koijima, Japan)


   Symposium 3. Novel Comprehensive Approaches to Schizophrenia Based on Vulnerability
      Stress Model
   1. A multichannel near-infrared spectroscopy study of frontal lobe function in schizophrenia
      and mood disorders (Masato Fukuda, Japan)
   2. Aberrant neural network of emplicit memory in schizophrenia: A spatio-temporal analysis
      (LORETA) of event-related potentials in repetition priming task. (Masaki Nakamura, Japan)
   3. Functional Deficits and Cognition in Schizophrenia (Tae-Yeon Hwang, Korea)
   4. Prefrontal functions in schizophrenic patients and their clinical correlations. (Sung Kil Min,
      Korea)


   Symposium 4. Clinical Investigations


   Symposium 5. Recent Advances in Functional Neuroimaging in Asia
   1. Neuroreceptor imaging of schizophrenia and antipsychotic drug action (Yoshiro Okubo,
      Japan)
   2. Functional MRI studies on face recognition (Masao Omori, Japan)
   3. Working memory processing of facial images in patients with schizophrenia: fMRI
      investigation (Chang-Uk Lee and Chul Lee, Korea)
   4. Voluntary eye movements abnormalities and functional MRI study of schizophrenia (Masato
      Matsuura, Japan)
   5. Abnormal functional connectivity in schizophrenia (Dae-Jin Kim, korea)
  Symposium 6a. Current Topics Among Young Psychiatrists – Part1 (The Current Biological
     Researches by Young Psychiatrists in Asia)
  1. Neurotrophic factors and psychiatric disorders: BDNF and psychiatric disorders: BDNF and
     psychiatric diseases (Naoe Okamura, Japan)
  2. Neurotrophic factors and psychiatric disorders: In vitro findings supporting a novel theory of
     depression (Masaru Tateno, Japan)
  3. The effects of Mirtazapine on the brain metabolism of depressed patients: Preliminary study
     (Yoon Yong Nam, Korea)
  4. Neural basis of emotional dysfunction in schizophrenia (Hidehiko Takahashi)
  5. Neuroimaging of psychiatric disorders (Takefumi Ueno, Japan)
  6. Association between a G-protein ß3 subunit gene polymorphism and the symptomatology
     and treatment responses of major depressive disorders (Heon-Jeong Lee, Korea)
  7. Volumetric magnetic resonance imaging study in schizophrenia (Gaku Okugawa, Japan)
  8. Representation of self recognition in patients with schizophrenia: H2O PET study (Tak Youn,
     Korea)


  Symposium 6b. Current Topics Among Young Psychiatrists – Part2 (For the Development of
     Biological Psychiatry in Asia)
  1. Recent advance of biological psychiatry in Korea (Chang-Su Han, Korea)
  2. For the development of biological psychiatry among Asian young psychiatrists (Masaru
     Tateno, Japan)


  Symposium 7. Biological and Clinical Updates on Suicide
  1. Clinical management of suicidal patient (David Horgan, Australia)
  2. Biological correlates of youth suicide (Graham Martin, Australia)
  3. Suicide on schizophrenia (Andras Perenyi, Australia)



5. Pre-WFSBP 심포지움
  일시: 2004년 7월 8일
  장소: 가톨릭대학교 의과학연구원
  주제: TMS 실기 workshop


  자기는 어떻게 두뇌를 자극하는가? – 기본적 이해 – (Basics of magnetic brain
  stimulation)                                          이창욱 (가톨릭의대)
  TMS는 두뇌에 어떠한 영향을 주는가? – 동물실험모형을 이용한 기초연구 – (Effects of
  TMS on brain - experimental animal model)             김현택 (고려대 행동심리학)
  TMS는 실제 환자에서 어떠한 효과가 있는가? – 임상 실제 – (Effects of rTMS in clinical
  practice)                                             채정호 (가톨릭의대)
  TMS – from basics to clinical application             Ziad   Nahas     (Medical   University   of
                                                      South Carolina)
   국내에서 사용가능한 TMS 장비 시연회 (displaying TMS machines)
   TMS 사용 술기 실습 (TMS in hands)


6. 2004 세계생물정신의학회 아시아·태평양 학술대회

(2004 WFSBP Asia-Pacific Congress and 41st Meeting of KSBP)


 1) 기간
     2004년 7월 9일(금) ~ 11일(일)
 2) 장소
     서울 신라호텔
 3) 주제
       -   Bridging between East & West Biological Psychiatry
       -   Bridging between Basic & Clinical Neuroscience

 4) 대회구성
       -   공식행사 (개회식, 폐회식)

       -   Symposium (17개 세션, 67개 논문 발표)

       -   Young Psychiatrists Session (1개 세션, 8개 논문 발표)

       -   Educational Workshop (1개, 3개 강의 및 실습)

       -   Free Communication (2개 세션, 7개 논문 발표)

       -   Poster Session (122논문발표)

       -   전시 (11개 업체, 17개 부스)

       -   사교행사 (환영연, 만찬)

 5) Scientific Program

     7월 9일 (금)


     Plenary 1
     Genomic Research of Schizophrenia: From Candetate Gene and Pharmacogenetic
     Approach to Whole Genome Study. Norio Ozaki (Nagoya University School of Medicine,
     Japan)
     Symposium 1A: Biological Marker of Schizophrenia
     1A-1: D-Serine as a Biological Marker of Schizophrenia. Kenji Hashimoto (Chiba University,
            Japan)
     1A-2: Functional and Structural Abnormalities in First Episode Schizophrenia. Yoshio
            Hirayasu (Yokohama City University School of Medicine, Japan)
1A-3: Exploratory Eye Movements as a Marker of Schizophrenia
      Eisuke Matsusima (Tokyo Medical and Dental University, Japan)
1A-4: P300 in Patients with Schizophrenia
      Yang-Whan Jeon (The Catholic University College of Medicine, Korea)
1A-5: Plasma BDNF Level in Psychiatric Patients and Normal Controls
      Siu Wa Tang (Queen Mary Hospital, University of Hong Kong, Hong Kong)


Symposium 1B: Bipolar Disorder; From Basic to
1B-1: Lithium Treatment: Mechanism of Action and Recent Clinical Data
      Hans-Jürgen Möller (Psychiatric Hospital, the University of Munich, Germany)
1B-2: Valproate in the Treatment of Bipolar Disorder from Clinical to Basic Research
      Yasumasa Okamoto (Hiroshima University, Japan)
1B-3: Bipolar Depression: Diagnosis and Its Implication on the Course of Bipolar Disorder
      Kyoo-Seob Ha (Seoul National University College of Medicine, Korea)
1B-4: Trends of Prescribing Mood Stabilizers and Antipsychotics for Bipolar Patients in Korea
      across a 15-year Span. Han-Yong Jung (Soonchunhyang University College of
      Medicine, Korea)
1B-5: Korean Medication Algorithm for Bipolar Disorders
      Won-Myong Bahk (The Catholic University College of Medicine, Korea)


Symposium 1C: Post-traumatic Stress Disorder
1C-1: The Prevalence and the Analysis of Variables in Veterans with Posttraumatic Stress
      Disorder. Moon-Yong Chung (Seoul Veterans Hospital, Korea)
1C-2: Structural and Functional Brain Abnormalities in PTSD. Hidenori Yamasue (University
      of Tokyo Graduate School of Medicine, Japan)
1C-3: Functional MRI Study on Effect of EMDR in PTSD during Script-driven Imagery. Joon-
      Ho Choi (Hanyang University School of Medicine, Korea)
1C-4: Compassion of Factor Structure of the Temperament and Character Inventory
      between Traumatized Group and Normative Group
      Hong-Seock Lee (The Catholic University College of Medicine, Korea)


Pfizer Satellite Symposium: Therapy Moves Forwards!
1. Changing the Face of Long Term Treatment: beyond Positive Symptoms
  Daniel Crane (New York University, USA)
2. Disturbances of Weight, Lipids, and Glucose Metabolism Associated with Antipsychotic
  Treatment.   Dan Haupt (Washington University, USA)
Poster Session 1


Symposium 2A: Cognitive
2A-1: TMS fMRI As a New Neuroscience Research Tool.        Ziad Nahas (Medical University of
      South Carolina, USA)
2A-2: Experience of Repetitive Transcranial Magnetic Stimulation on Depression and
          Cognition in Taiwan. Tung-Ping Su (National Yang-Ming University, Taiwan)
2A-3: Experiences of TMS in Korea. Jeong-Ho Chae (The Catholic University College of
          Medicine, Korea)
2A-4: Molecular Exploration of Brain Stimulation. Kun-Woo Park (Korea University College of
      Medicine, Korea)


Symposium 2B: Neuroimaging
2B-1: Early Diagnosis of Alzheimer’s Disease by Brain Imaging
          Hiroshi Matsuda (Saitama Medical School Hospital, Japan)
2B-2: Receptor Occupancy and Psychotropic Drug Action Measured by PET
          Tetsuya Suhara (National Institute of Radiological Sciences, Japan)
2B-3: Morphological Brain Changes in Schizophrenia and Possibility of Diagnosis by MRI
          Michio Suzuki (Toyama Medical and Pharmaceutical University, Japan)
2B-4: Working Memory Processing of Facial Images in Schizophrenia: fMRI Investigation
          Chang-Uk Lee (The Catholic University College of Medicine, Korea)


Symposium 2C: Geriatric
2C-1: Molecular Pathogenesis of Dementia in the Elderly
          Masatoshi Takeda (Osaka University Medical School, Japan)
2C-2: A Study on the Frequencies of Apolipoprotein E Alleles and Their Relationship with
          Cognitive Function of the Elderly Living in Korea
          Byeong-Kil Yeon (Hallym University College of Medicine, Korea)
2C-3: Acetylcholinesterase Inhibitor Treatment Response in Korean Elderly Alzheimer's
          Disease Patients. Byoung-Hoon Oh (Yonsei University College of Medicine, Korea)
2C-4: Age Associated Memory Impairment in the Elderly Chinese Malaysians
      Saroja Krishnaswamy (Hospital Universiti Kebangsaan, Malaysia)


Lilly Satellite Symposium: Clinical Outcome and Management of Schizophrenia
1. Schizophrenia Outpatient Health Outcomes (Asia 12 Month Data)
  Chang-Yoon Kim (Ulsan University College of Medicine, Korea)
2. The Acute Relapse; Gaining Symptom Control
  Barry Jones (McMaster University, Canada)


7월 10일 (토요일)


Plenary 2
Antidepressants as Inflammatory Cytokine Antagonists-A Novel Method of Antidepressant
Action?
Brian Edmund Leonard (National University of Ireland, Galway, Ireland)
Symposium 3A:
3A-1: Genetic Advances in Schizophrenia Using Alternative Strategies
      Florence Thibaut (Rouen University Hospital, France)
3A-2: Structural Abnormalities in Early-Onset Schizophrenia Patients: An Voxel-Based MRI
      Study.   Nori Takei (Hamamatsu University School of Medicine, Japan)
3A-3: Outcome-oriented Approach in Schizophrenia. Tae-Yeon Hwang (Yongin Mental
      Hospital, Korea)
3A-4: Anticipation of Schizophrenia? - Retrospective and 25 Year Prospective Studies -
     Yuji Okazaki (Mie University Faculty of Medicine, Japan)
3A-5: Clinical and Genetic Correlates of Violent behavior in Schizophrenic Patients
     Sung-Kil Min (Yonsei University College of Medicine, Korea)


Symposium 3B: Novel Approaches in the Treatment of Depression
3B-1: Pharmacogenetic Approaches to Antidepressant Treatment : the Response to SSRIs
     and Neurotransmission Related Genes
     Min-Soo Lee (Korea University College of Medicine, Korea)
3B-2: The Management of Patients Suffering from Treatment Resistant Depression: An
     Update. Isaac Schweitzer (The Melbourne Clinic, University of Melbourne, Australia)
3B-3: Treatment of Bipolar Depression: Problems and Solutions
      José Luis Ayuso-Gutiérrez (Complutense University. Madrid, Spain)
3B-4: Near-infrared Spectroscopy Study of Depression and Bipolar Disorder
     Masato Fuduka (Gunma University Graduate School of Medicine, Japan)


Symposium 3C: Obsessive Compulsive Disorder
3C-1: Neuropsychology of OCD. Katsuro Takahashi (Nagasaki Medical Center of Psychiatry,
     Japan)
3C-2: Probing Neural Curcuits in OCD. Tak Youn (Chook Ryoung Evangelical Hospital,
      Korea)
3C-3: Is There a Role for Antipsychotics in OCD? Joseph Zohar (Chaim Sheba Medical
      Center, Israel)
3C-4: Neurosurgical Intervention for Refractory OCD. Chan-Hyung Kim (Yonsei University
      College of Medicine, Korea)


Free Communication 1: Genetic Polymorphism and Psychiatric Disorders
F1-1: Effect of Defect in CYP2C19 Gene on Clinical Outcome of Schizophrenic Patients
     Andi Jayalangkara Tanra (Hasanuddin University. Makassar, Indonesia)
F1-2: No Association between TPH Gene and Depression
     Byung-Joo Ham (Korea University College of Medicine, Korea)
F1-3: Functional Polymorphisms of the Alcohol-Metabolism Genes and Associations with the
     Risk of Alcoholism in Korean Population
     Ihn-Geun Choi (Hallym University College of Medicine, Korea)
F1-4: MAO-A Polymorphism and Treatment Response in Patients with Panic Disorder
     Young-Hee Choi (Inje University College of Medicine, Korea)


GSK Satellite Symposium: Future Management of Mood and Anxiety Disorders
1. Limitations and Current Strategies for the Treatment of Depression and Anxiety Disorders
   Doh-Kwan Kim (Sungkyunkwan University School of Medicine, Korea)
2. Making Advances Where It Matters. Rajinder Kumar (MeRaD pharmaceuticals Ltd. UK)
3. Beyond Mood and Anxiety Disorders. Meir Steiner (McMaster University, Canada)


Poster Session 2


Symposium 4A: Neurobehavioral Genetics
4A-1: Candidate Gene Association Studies for Neuropsychiatric Disorders
      Eun-Jeong Joo (Eulji University School of Medicine, Korea)
4A-2: Positional Cloning of Susceptibility Genes for Neuropsychiatric Disorders
      Kyung-Sue Hong (Sungkyunkwan University School of Medicine, Korea)
4A-3: Neonatal Isolation, Gene Expression, and Stress Vulnerability
      Shigeru Morinobu (Hiroshima University, Hiroshima, Japan)
4A-4: Pharmacogenomics and Depression Research: Antidepressant-elicited Changes in
      Gene Expression. Mitsuhiko Yamada (Showa University School of Medicine, Japan)


Symposium 4B: Clinical and Genetic Manifestation of Narcolepsy
4B-1: The Pathophysiology of Narcolepsy. Emmanuel Mignot (Stanford University, USA)
4B-2: HLA-DQB1*0602 and Hypocretin in Korean Narcoleptic Patients
     Seung-Chul Hong (The Catholic University College of Medicine, Korea)
4B-3: Secondary Narcolepsy due to Hypocretin-1 (orexin-A)-Deficiency
     Takashi Kanbayashi (Akita University Hospital, Japan)


Symposium 4C: Social Phobia
4C-1: Social Phobia-Serotonin Hypothesis and Clinical Experiences in Japan
      Takeshi Inoue (Hokkaido University Graduate School of Medicine, Japan)
4C-2: Genetic Polymorphism of Dopamine Transporter Gene (DAT1) and Serotonin
      Transporter Gene (5-HTTLPR) in Korean Social Phobia Patients
      Kang-Seob Oh (Sungkyunkwan University School of Medicine, Korea)
4C-3: Brain Imaging Studies in Social Phobia
     Byung-Joo Ham (Hallym University College of Medicine, Korea)
4C-4: Relationship of Childhood Anxiety to Adult Social Phobia in Korea
     Younhee Oh (Kangbuk Samsung Hospital, Korea)


Young Psychiatrists Session Symposium 1: Current Topics in Schizophrenia
1. Neuroimaging Study of Cerebellum in Schizophrenia. Gaku Okugawa (Kansai Medical
     University, Japan)
2. Cognition in Schizophrenia. Bum- Seok Jeong (Eulji University School of Medicine, Korea)
3. Clinical Pharmacotherapy in Chronic Schizophrenia. Souichiro Sato (Okayama Jikei
     Hospital, Japan)
 Discusssants        1. Norio Ozaki (Nagoya University School of Medicine, Japan)
                     2. Joseph Zohar (Chaim Sheba Medical Center, Israel)


Young Psychiatrists Symposium 2: Current Topics in Depression
1. Genetic Polymorphisms and Depression. Heon-Jeong Lee (Korea University College of
     Medicine, Korea)
2.Epidemic of Senile Depression in Rural Area in Japan. Yayoi Koizumi (Tohoku University,
     Japan)
3. Factors for Treatment Response in Patients with Depression. Jong- Min Woo (Inje
     University College of Medicine, Korea)
Discusssants         1. Jeong-Ho Chae (The Catholic University College of Medicine, Korea)
                     2. Shigenobu Kanba (Kyushu University, Japan)
Young Psychiatrists Brief Lecture 1
Novel Aspects of Pathphysiology of Alcohol Dependence. Masaru Tateno (Sapporo Medical
University, Japan)
 Young Psychiatrists Brief Lecture 2
Beyond Biology in Psychiatry
Byoong-Nyun Kim (Seoul National University College of Medicine, Korea)


Janssen Satellite Symposium: Long Term Management of Psychosis
1. The Present and Future Role of Long Acting Atypical Antipsychotics
     Timothy Lambert (University of Melbourne, Australia)
2.    Pharmaceutical      and   Pharmacokinetic   Considerations   of   Long   Acting   Atypical
     Antipsychotic. Chan-Hyung Kim (Yonsei University College of Medicine, Korea)


7월 11일 (일요일)


Educational Workshop on Clinical Investigations
 Research Design Issues
Angelos Halaris (Loyola University Medical Center, USA)
Joseph Zohar (Chaim Sheba Medical Center, Israel)
 Research Design Issues
Angelos Halaris (Loyola University Medical Center, USA)
Joseph Zohar (Chaim Sheba Medical Center, Israel)
Joong-Seo Yi (Hallym University Medical Center, Korea)
 Ethical Issues
Angelos Halaris (Loyola University Medical Center, USA)
Regulatory Issues
Angelos Halaris (Loyola University Medical Center, USA)
Joseph Zohar (Chaim Sheba Medical Center, Israel)
In-Jin Jang (Seoul National University Hospital, Korea)
Practical Exercise
Angelos Halaris (Loyola University Medical Center, USA)
Joseph Zohar (Chaim Sheba Medical Center, Israel)


Plenary 3
Gene Expression Patterns in Neuropsychiatric Disorders
Kevin G. Becker (National Institute on Aging, NIH, USA)


Symposium 5A: Clinical and Preclinical Implication of Neuroimmunology in Psychiatry
5A-1: The Role of Cytokine Network in Schizophrenia. Yong-Ku Kim (Korea University
       College of Medicine, Korea)
5A-2: Cytokine-Serotonin System Interaction through IDO in Major Depression
       Aye-Mu Myint (Maastricht University, Netherlands)
5A-3: The Olfactory Bulbectomised Rat Model of Depression-30 years On
      Brian Edmund Leonard (National University of Ireland, Galway, Ireland)


5B: Stimulant-induced Psychosis
5B-1: Etiological and Clinical Aspects of Methamphetamine-induced Psychiatric Disorders in
      Japan. Shigeru Ozaki (National Institute of Mental Health, Japan)
5B-2: Genetic Factors for Methamphetamine Dependence and Psychosis
      Hiroshi Ujike (Okayama University Graduate School of Medicine and Dentistry, Japan)
5B-3: Neuroimaging Study on Methamphetamine Psychosis
       Yoshimoto Sekine (Hamamatsu University School of Medicine, Japan)
5B-4: Aspects of Methamphetamine Dependence in Korea
       Dai-Jin Kim (The Catholic University College of Medicine, Korea)


Symposium 5C: Cross-National Variations in the Drug Treatment of Schizophrenia and
                     Bipolar disorder
5C-1: Cross National Variations in the Drug Treatment of Schizophrenia
       Timothy Lambert (University of Melbourne, Australia)
5C-2: Drug Treatment of Schizophrenia in Thailand: A Report from an Outpatient Audit
      Pichet Udomratn (Songkla University, Thailand)
5C-3: Cross-Cultural Comparison of Community Prescribing Patterns in Schizoprenia
       Chee Ng (The University of Melbourne, Australia)
5C-4: A Trend of Drug Use in Patients with Bipolar Disorder: 4-Year Naturalistic Study
       Kyoung-Uk Lee (The Catholic University College of Medicine, Korea)
Sanofi~Synthelabo Satellite Symposium: A Excellent Choice among Antipsychotics
1. Review of Amisulpride: Focused on Efficacy and Safety
   Tae-Youn Jun (The Catholic University College of Medicine, Korea)
2. Could We Improve the Negative Symptomatology of Schizophrenia?
   Florence Thibaut (Rouen University Hospital, France)


Symposium 6A: Biological Evaluation and Management of Alcohol Dependence
6A-1: Neurobiology of Alcoholism
     Brian Edmund Leonard (National University of Ireland, Galway, Ireland)
6A-2: Biochemical Diagnosis of Alcohol Dependence
     Ihn-Geun Choi (Hallym University College of Medicine, Korea)
6A-3: Electrophysiological Aspects of Alcohol Dependence
     Dai-Jin Kim (The Catholic University College of Medicine, Korea)
6A-4: Biological Treatments of Alcohol Dependence
     Sung-Gon Kim (Pusan National University College of Medicine, Korea)


Symposium 6B: Traditional Oriental Medicine
6B-1: The Effects on Jowiseungchungtang of Patients with Early DAT Using Auditory ERP
       and K-DRS. Jong-Woo Kim (Kyunghee University College of Medicine, Korea)
6B-2: Japanese Traditional Medicine in the Field of Psychiatry. Kazuo Yamada (Yamanashi
       University, Interdisciplinary Graduate School of Medicine and Engineering, Japan)
6B-3: Comparative Study of Electroacupuncture and Fluoxetine for Treatment of Depression
     He-chun Luo (Peking University, China)
6B-4: Antidepressant Action of Kami-shoyosan
     Young-Hoon Kim (Inje University College of Medicine, Korea)
6B-5: Anxiolytic-like Effects of Sanjoin-Tang in Mice
     Jong-Hoon Ryu (Kyung Hee University College of Medicine, Korea)


Free Communication 2: Miscellaneous
F2-1: P300A and P300B in Patients with Schizophrenia
     Yang-Whan Jeon (The Catholic University College of Medicine, Korea)
F2-2: Biofeedback Can Change Alpha and Beta Waves in the Brain
     Anne John (Hospital Universiti Kebangsaan, Malaysia)
F2-3: The Relationship of Neurocognitive Functioning and Emotional Perception in Chronic
     Schizophrenia. Tae-Yeon Hwang (Yongin Mental Hospital, Korea)
F2-4: Tolerability of Increment of Oros Methylphenidate in Children with ADHD
       Soyoung Irene Lee (Soonchunhyang University College of Medicine, Korea)


Plenary 4
An Energetic Theory for Schizophrenia. Carlos Roberto Hojaij (The Melbourne Clinic,
Australia)

				
DOCUMENT INFO